Efficacy and safety of bifonazole urea in the two-phase treatment of onychomycosis.
Bonifaz
A
A
Dermatology Unit, Hospital General de México, México D.F.
Guzmán
A
A
Garcia
C
C
Sosa
J
J
Saúl
A
A
D000287:Administration, Topical; D000293:Adolescent; D000328:Adult; D000368:Aged; D000935:Antifungal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D003131:Combined Modality Therapy; D004334:Drug Administration Schedule; D005260:Female; D005533:Foot Dermatoses / Q000188:drug therapy / Q000503:physiopathology; D006229:Hand Dermatoses / Q000188:drug therapy / Q000503:physiopathology; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D014009:Onychomycosis / Q000188:drug therapy* / Q000503:physiopathology / Q000628:therapy; D011446:Prospective Studies; D016896:Treatment Outcome
D000935:Antifungal Agents; D007093:Imidazoles; C036596:bifonazole